熱門資訊> 正文
Chromocell宣布股票回购计划
2024-08-07 21:10
- Chromocell Therapeutics (NYSE:CHRO) on Wednesday announced a stock repurchase plan of up to $250,000 of Chromocell’s common stock, which represents about 23% of the non-affiliate float based on the closing price of the company’s common stock as of August 6.
- CHRO -22.38% premarket to $0.78.
- Source: Press Release
More on Chromocell Therapeutics Corporation
- Financial information for Chromocell Therapeutics Corporation
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。